Dibenzazepine-Loaded Nanoparticles Induce Local Browning of White Adipose Tissue to Counteract Obesity
Obesity, a poor diet, and lack of exercise are the main causes of the rise in newly diagnosed Type 1 and Type 2 diabetes cases
Available 1 mg/0.5 mL Available according to the FDA and were receiving no reports of supply issues
More Magazines Recommendations Info Press release Sanofi-aventis New ADA/EASD Treatment Recommendations Timely Use of Basal Insulin reinforced as a Core Therapy for Type 2 Diabetes - Experts recommend considering a basal insulin or sulfonylurea when treatment goals not achieved with metformin alone - Paris, France - October 30, 2008 Sanofi-aventis commends the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) for developing updated treatment recommendations for type 2 diabetes
Sometimes, stomach pain is more severe before eating, while at other times, it intensifies after a meal
Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study